Literature DB >> 8666772

Epicutaneous exposure of protein antigen induces a predominant Th2-like response with high IgE production in mice.

L F Wang1, J Y Lin, K H Hsieh, R H Lin.   

Abstract

Hapten-induced contact hypersensitivity has been well-characterized in humans as well as in animal models. However, it is not clear whether or not protein Ag can directly sensitize epicutaneously and induce a primary immune response. We demonstrated in this study, for the first time, that through epicutaneous exposure protein Ag in the absence of adjuvant sensitizes animals and induces a predominant Th2-like response. Furthermore, mice receiving repeated protein Ag sustained elevated levels of specific IgE. This animal model can be used to investigate the molecular mechanism controlling the differential Th1/Th2 development in skin diseases.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8666772

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  33 in total

1.  Macroflux microprojection array patch technology: a new and efficient approach for intracutaneous immunization.

Authors:  James A Matriano; Michel Cormier; Juanita Johnson; Wendy A Young; Margaret Buttery; Kofi Nyam; Peter E Daddona
Journal:  Pharm Res       Date:  2002-01       Impact factor: 4.200

2.  Epicutaneous immunization induces alphabeta T-cell receptor CD4 CD8 double-positive non-specific suppressor T cells that inhibit contact sensitivity via transforming growth factor-beta.

Authors:  Marian Szczepanik; Krzysztof Bryniarski; Monika Tutaj; Maria Ptak; Joanna Skrzeczynska; Philip W Askenase; Wlodzimierz Ptak
Journal:  Immunology       Date:  2005-05       Impact factor: 7.397

3.  Epicutaneous immunization converts subsequent and established antigen-specific T helper type 1 (Th1) to Th2-type responses.

Authors:  Jessica Strid; Robin Callard; Stephan Strobel
Journal:  Immunology       Date:  2006-06-08       Impact factor: 7.397

Review 4.  Control of experimental autoimmune encephalomyelitis by CD4+ suppressor T cells: peripheral versus in situ immunoregulation.

Authors:  Margaret S Bynoe; Paula Bonorino; Christophe Viret
Journal:  J Neuroimmunol       Date:  2007-09-27       Impact factor: 3.478

5.  Th2 polarization enhanced by oral administration of higher doses of antigen.

Authors:  M Hashiguchi; S Hachimura; A Ametani; S Kaminogawa
Journal:  Cytotechnology       Date:  2000-07       Impact factor: 2.058

6.  Comorbidity in Atopic Dermatitis.

Authors:  Eric L Simpson
Journal:  Curr Dermatol Rep       Date:  2012-03-01

7.  Priming with high and low respiratory allergen dose induces differential CD4+ T helper type 2 cells and IgE/IgG1 antibody responses in mice.

Authors:  Kazuki Furuhashi; Yen L Chua; Kenneth H S Wong; Qian Zhou; Debbie C P Lee; Ka H Liong; Guo H Teo; Paul E Hutchinson; David M Kemeny
Journal:  Immunology       Date:  2017-04-03       Impact factor: 7.397

Review 8.  Langerhans cells as targets for immunotherapy against skin cancer.

Authors:  Patrizia Stoitzner; Florian Sparber; Christoph H Tripp
Journal:  Immunol Cell Biol       Date:  2010-03-30       Impact factor: 5.126

9.  Galectin-3 is critical for the development of the allergic inflammatory response in a mouse model of atopic dermatitis.

Authors:  Jun Saegusa; Daniel K Hsu; Huan-Yuan Chen; Lan Yu; Agnes Fermin; Maxwell A Fung; Fu-Tong Liu
Journal:  Am J Pathol       Date:  2009-01-29       Impact factor: 4.307

10.  The haemopoietic growth factor, Flt3L, alters the immune response induced by transcutaneous immunization.

Authors:  Maria E Baca-Estrada; Catherine Ewen; Donna Mahony; Lorne A Babiuk; Darryl Wilkie; Marianna Foldvari
Journal:  Immunology       Date:  2002-09       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.